DE BARTOLOMEIS, ANDREA
 Distribuzione geografica
Continente #
AS - Asia 7.056
EU - Europa 5.394
NA - Nord America 4.917
SA - Sud America 1.185
AF - Africa 226
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 18.787
Nazione #
US - Stati Uniti d'America 4.664
SG - Singapore 3.851
RU - Federazione Russa 2.654
CN - Cina 1.636
IT - Italia 1.047
BR - Brasile 979
HK - Hong Kong 638
VN - Vietnam 436
DE - Germania 371
FI - Finlandia 249
NL - Olanda 183
UA - Ucraina 172
GB - Regno Unito 171
IE - Irlanda 147
CA - Canada 135
CI - Costa d'Avorio 98
FR - Francia 96
SE - Svezia 87
MX - Messico 86
KR - Corea 79
AR - Argentina 77
IN - India 73
BD - Bangladesh 64
ZA - Sudafrica 47
AT - Austria 43
ID - Indonesia 43
JP - Giappone 43
ES - Italia 41
EC - Ecuador 38
PL - Polonia 38
TR - Turchia 32
IQ - Iraq 23
CO - Colombia 22
MA - Marocco 21
CL - Cile 19
PK - Pakistan 18
VE - Venezuela 18
BE - Belgio 16
AE - Emirati Arabi Uniti 15
LT - Lituania 13
UZ - Uzbekistan 12
PE - Perù 11
PY - Paraguay 11
IR - Iran 10
BG - Bulgaria 9
EG - Egitto 8
IS - Islanda 8
SA - Arabia Saudita 8
HU - Ungheria 7
CZ - Repubblica Ceca 6
IL - Israele 6
JO - Giordania 6
LA - Repubblica Popolare Democratica del Laos 6
NG - Nigeria 6
TN - Tunisia 6
TW - Taiwan 6
DO - Repubblica Dominicana 5
HN - Honduras 5
KE - Kenya 5
KG - Kirghizistan 5
OM - Oman 5
UY - Uruguay 5
AL - Albania 4
AU - Australia 4
BY - Bielorussia 4
DZ - Algeria 4
GE - Georgia 4
LB - Libano 4
MY - Malesia 4
NI - Nicaragua 4
SI - Slovenia 4
AO - Angola 3
AZ - Azerbaigian 3
BS - Bahamas 3
BW - Botswana 3
CH - Svizzera 3
CM - Camerun 3
ET - Etiopia 3
GA - Gabon 3
GR - Grecia 3
JM - Giamaica 3
KZ - Kazakistan 3
PA - Panama 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
BH - Bahrain 2
BO - Bolivia 2
CY - Cipro 2
DK - Danimarca 2
GF - Guiana Francese 2
HR - Croazia 2
MK - Macedonia 2
MN - Mongolia 2
NO - Norvegia 2
PT - Portogallo 2
RO - Romania 2
TG - Togo 2
TJ - Tagikistan 2
AD - Andorra 1
AF - Afghanistan, Repubblica islamica di 1
Totale 18.745
Città #
Singapore 1.761
Moscow 663
Hong Kong 628
Beijing 503
Chandler 443
Hefei 412
Ashburn 367
Santa Clara 309
Naples 219
Millbury 202
Jacksonville 173
Ho Chi Minh City 147
Los Angeles 147
Princeton 143
Amsterdam 135
Munich 116
Nanjing 114
Buffalo 103
Boston 93
Hanoi 92
São Paulo 89
Wilmington 88
Houston 86
Redondo Beach 84
Norwalk 78
Seoul 76
Des Moines 75
New York 75
Seattle 65
Ottawa 61
Rome 59
Napoli 55
Turku 52
Dallas 50
Helsinki 49
Nuremberg 46
Mexico City 45
Nanchang 44
Woodbridge 41
The Dalles 39
Brooklyn 38
Chicago 36
Lawrence 34
Frankfurt am Main 32
Milan 32
London 29
Rio de Janeiro 29
Shenyang 29
Denver 28
Falkenstein 28
Tokyo 28
Atlanta 27
Hebei 27
Changsha 26
Montreal 25
Belo Horizonte 24
Dong Ket 24
Orem 24
Warsaw 24
Jiaxing 23
Johannesburg 22
Kronberg 20
Boardman 19
Falls Church 19
Stockholm 19
Toronto 19
Ankara 18
Brasília 18
Chennai 18
Poplar 18
Biên Hòa 17
Curitiba 16
Düsseldorf 16
Lappeenranta 16
Phoenix 16
Portici 16
Dhaka 15
Dublin 15
San Francisco 15
Tianjin 15
Brussels 14
Da Nang 14
Haiphong 14
Quito 14
Salvador 14
Vienna 14
Porto Alegre 13
Subottsi 13
Guangzhou 12
Bari 11
Catania 11
Guarulhos 11
Shanghai 11
Campinas 10
Hải Dương 10
Ninh Bình 10
Redwood City 10
Tashkent 10
Bexley 9
Cape Town 9
Totale 9.175
Nome #
Pharmacological interventions for antipsychotic-related sialorrhea: a systematic review and network meta-analysis of randomized trials 140
A role for D-aspartate oxidase in schizophrenia and in schizophrenia-related symptoms induced by phencyclidine in mice 136
Regulation of postsynaptic plasticity genes' expression and topography by sustained dopamine perturbation and modulation by acute memantine: Relevance to schizophrenia 134
M170. GENETIC CHARACTERIZATION OF A COHORT OF PATIENTS AFFECTED BY SCHIZOPHRENIA. THE ROLE FOR RARE STRUCTURAL VARIANTS IN MODULATING TREATMENT RESISTANT ENDOPHENOTYPES: PRELIMINARY DATA 127
Current and future perspectives on the Major Depressive Disorder: Focus on the new multimodal antidepressant Vortioxetine 124
Prevalence and correlates of major depressive disorder, bipolar disorder and schizophrenia among nursing home residents without dementia: systematic review and meta-analysis 123
Cognitive correlates of borderline intellectual functioning in borderline personality disorder 123
D-aspartate dysregulation in Ddo-/- mice modulates phencyclidine-induced gene expression changes of postsynaptic density molecules in cortex and striatum 122
Psychological distress in serious mental illness patients during the COVID-19 outbreak and one-month mass quarantine in Italy 122
Antipsychotics-Induced Changes in Synaptic Architecture and Functional Connectivity: Translational Implications for Treatment Response and Resistance 119
The effects of sustained COVID-19 emergency and restrictions on the mental health of subjects with serious mental illness: A prospective study 119
Psychopharmacology of eating disorders: Systematic review and meta-analysis of randomized controlled trials 117
Disease Severity in Treatment Resistant Schizophrenia Patients Is Mainly Affected by Negative Symptoms, Which Mediate the Effects of Cognitive Dysfunctions and Neurological Soft Signs 117
The emerging role of dopamine-glutamate interaction and of the postsynaptic density in bipolar disorder pathophysiology: Implications for treatment 116
Transcranial direct current stimulation for obsessive–compulsive disorder: A randomized, controlled, partial crossover trial 116
Re-arrangements of gene transcripts at glutamatergic synapses after prolonged treatments with antipsychotics: A putative link with synaptic remodeling 114
The Glucocorticoid Analog Dexamethasone Alters the Expression and the Distribution of Dopamine Receptors and Enkephalin within Cortico-subcortical Regions. 113
Incidence, prevalence and clinical correlates of antidepressant-emergent mania in bipolar depression: a systematic review and meta-analysis 113
Disorganization domain as a putative predictor of Treatment Resistant Schizophrenia (TRS) diagnosis: A machine learning approach 112
Decreased gene expression of calretinin and ryanodine receptor type 1 in tottering mice 112
Neural substrates of verbal memory impairment in schizophrenia: A multimodal connectomics study 108
Transcranial direct current stimulation for bipolar depression: systematic reviews of clinical evidence and biological underpinnings 106
Postsynaptic density protein transcripts are differentially modulated by minocycline alone or in add-on to haloperidol: Implications for treatment resistant schizophrenia 106
Switching antipsychotics: Imaging the differential effect on the topography of postsynaptic density transcripts in antipsychotic-naïve vs. antipsychotic-exposed rats 104
Assessing patient-rated vs. clinician-rated adherence to the therapy in treatment resistant schizophrenia, schizophrenia responders, and non-schizophrenia patients 103
Psychiatric Symptoms in Parkinson’s Disease Patients before and One Year after Subthalamic Nucleus Deep Brain Stimulation Therapy: Role of Lead Positioning and Not of Total Electrical Energy Delivered 102
Interplay among psychopathologic variables, personal resources, context-related factors, and real-life functioning in individuals with schizophrenia a network analysis 102
Acute administration of antipsychotics modulates Homer striatal gene expression differentially 101
Nicotine and caffeine modulate haloperidol-induced changes in postsynaptic density transcripts expression: Translational insights in psychosis therapy and treatment resistance 101
Homer splice variants modulation within cortico-subcortical regions by dopamine D2 antagonists, a partial agonist, and an indirect agonist: implication for glutamatergic postsynaptic density in antipsychotics action 100
Antipsychotic and antidepressant co-treatment: effects on transcripts of inducible postsynaptic density genes possibly implicated in behavioural disorders 100
Chronic treatment with lithium or valproate modulates the expression of Homer1b/c and its related genes Shank and Inositol 1,4,5-trisphosphate receptor 100
Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant predictor of poorer achievements in functional milestones 100
The identification of biomarkers predicting acute and maintenance lithium treatment response in bipolar disorder: A plea for further research attention 100
Cerebellar transcranial direct current stimulation in children with autism spectrum disorder: A pilot study on efficacy, feasibility, safety, and unexpected outcomes in tic disorder and epilepsy 100
Vein wall thickness and severity of pulmonary involvement due to sars n-cov2 virus infection 99
Treatment resistant schizophrenia and neurological soft signs may converge on the same pathology: Evidence from explanatory analysis on clinical, psychopathological, and cognitive variables 99
Clinical and psychopathological features associated with treatment-emergent mania in bipolar-II depressed outpatients exposed to antidepressants 99
Immediate-early genes modulation by antipsychotics: Translational implications for a putative gateway to drug-induced long-term brain changes 99
Aripiprazole-induced atrial fibrillation in a patient with concomitant risk factors 99
Depression and Anxiety Symptoms "Among the Waves" of the COVID-19 Pandemic in Obsessive Compulsive Disorder and Adjustment Disorder Patients 98
Insomnia and related mental health conditions: Essential neurobiological underpinnings towards reduced polypharmacy utilization rates 98
Patients with poor response to antipsychotics have a more severe pattern of frontal atrophy: a voxel-based morphometry study of treatment resistance in schizophrenia. 98
New advances in the treatment of generalized anxiety disorder: The multimodal antidepressant vortioxetine 98
Clinical evaluation of functional capacity in treatment resistant schizophrenia patients: Comparison and differences with non-resistant schizophrenia patients 98
The efficacy, safety, and adverse events of azapirones in anxiety disorders: A systematic review and meta-analysis of randomized controlled trials 97
Dopamine Dynamics and Neurobiology of Non-Response to Antipsychotics, Relevance for Treatment Resistant Schizophrenia: A Systematic Review and Critical Appraisal 97
Factor structure and reliability of the Italian adaptation of the Hypomania Check List-32, second revision (HCL-32-R2). 97
Homer 1a gene expression modulation by antipsychotic drugs: involvement of the glutamate metabotropic system and effects of D-cycloserine 97
Antidepressants activate CaMKII in neuron cell body by Thr286 phosphorylation 97
Pattern of acute induction of Homer1a gene is preserved after chronic treatment with first and second-generation antipsychotics: effect of short-term drug discontinuation and comparison with Homer1a-interacting genes. 97
The acute and chronic effects of combined antipsychotic-mood stabilizing treatment on the expression of cortical and striatal postsynaptic density genes 97
Calcium-dependent networks in dopamine-glutamate interaction: the role of postsynaptic scaffolding proteins 97
Dandy-Walker Syndrome with psychotic symptoms: A case report 97
Update on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies beyond Dopamine Receptor Antagonism 97
Predictors of hospitalization length of stay among re-admitted treatment-resistant Bipolar Disorder inpatients 97
Clinical features associated with early drop-out among outpatients with unipolar and bipolar depression 97
The hypertension of Cushing's syndrome: controversies in the pathophysiology and focus on cardiovascular complications 97
Perinatal stress modulates glutamatergic functional connectivity: A post-synaptic density immediate early gene-based network analysis 96
Homelessness and health-related outcomes: an umbrella review of observational studies and randomized controlled trials 96
Altered Patterns of Brain Glucose Metabolism Involve More Extensive and Discrete Cortical Areas in Treatment-resistant Schizophrenia Patients Compared to Responder Patients and Controls: Results From a Head-to-Head 2-[18F]-FDG-PET Study 96
Divergent acute and chronic modulation of glutamatergic postsynaptic density genes expression by the antipsychotics haloperidol and sertindole. 96
CHD2 mutations: Only epilepsy? Description of cognitive and behavioral profile in a case with a new mutation 96
Pharmacological treatments for psychotic depression: a systematic review and network meta-analysis 95
Treatment-resistant schizophrenia: Addressing white matter integrity, intracortical glutamate levels, clinical and cognitive profiles between early- and adult-onset patients 95
MicroRNAs in Schizophrenia: Implications for Synaptic Plasticity and Dopamine–Glutamate Interaction at the Postsynaptic Density. New Avenues for Antipsychotic Treatment Under a Theranostic Perspective 95
Polarity-dependent effects of transcranial direct current stimulation in obsessive-compulsive disorder 95
Update on novel antipsychotics and pharmacological strategies for treatment-resistant schizophrenia 95
Decreased free D-aspartate levels in the blood serum of patients with schizophrenia 94
The prevalence, odds, predictors, and management of tobacco use disorder or nicotine dependence among people with severe mental illness: Systematic review and meta-analysis 94
Dysregulated Signaling at Postsynaptic Density: A Systematic Review and Translational Appraisal for the Pathophysiology, Clinics, and Antipsychotics' Treatment of Schizophrenia 94
d-Aspartate drinking solution alleviates pain and cognitive impairment in neuropathic mice 94
Treating the Synapse in Major Psychiatric Disorders: The Role of Postsynaptic Density Network in Dopamine-Glutamate Interplay and Psychopharmacologic Drugs Molecular Actions 94
Schizophrenia Synaptic Pathology and Antipsychotic Treatment in the Framework of Oxidative and Mitochondrial Dysfunction: Translational Highlights for the Clinics and Treatment 94
Defining clinical characteristics of emotion dysregulation in bipolar disorder: A systematic review and meta-analysis 93
Progressive recruitment of cortical and striatal regions by inducible postsynaptic density transcripts after increasing doses of antipsychotics with different receptor profiles: insights for psychosis treatment 93
Palmitoylethanolamide reduces pain-related behaviors and restores glutamatergic synapses homeostasis in the medial prefrontal cortex of neuropathic mice 92
Efficacy and safety of selegiline across different psychiatric disorders: A systematic review and meta-analysis of oral and transdermal formulations 91
Clozapine's multiple cellular mechanisms: What do we know after more than fifty years? A systematic review and critical assessment of translational mechanisms relevant for innovative strategies in treatment-resistant schizophrenia 91
Relationships between early age at onset of psychotic symptoms and treatment resistant schizophrenia 91
Fisiopatologia cellulare e molecolare 91
Antypsychotic induced gene expression in the rat brain: a computational and experimental approach 91
Glutamatergic Postsynaptic Density Protein Dysfunctions in Synaptic Plasticity and Dendritic Spines Morphology: Relevance to Schizophrenia and Other Behavioral Disorders Pathophysiology, and Implications for Novel Therapeutic Approaches. 91
Glutamatergic postsynaptic density in early life stress programming: Topographic gene expression of mGlu5 receptors and Homer proteins 91
Prominent autistic traits and subthreshold bipolar/mixed features of depression in severe anorexia nervosa 91
The Effects of Antipsychotics on the Synaptic Plasticity Gene Homer1a Depend on a Combination of Their Receptor Profile, Dose, Duration of Treatment, and Brain Regions Targeted 91
Emotion dysregulation in bipolar disorder compared to other mental illnesses: a systematic review and meta-analysis 90
Dopamine receptor subtypes contribution to Homer1a induction: Insights into antipsychotic molecular action 90
Striatal expression of Homer1a is affected by genotype but not dystonic phenotype of tottering mice: a model of spontaneously occurring motor disturbances 90
The emergence of loss of efficacy during antidepressant drug treatment for major depressive disorder: An integrative review of evidence, mechanisms, and clinical implications 90
Plasma HVA, tardive dyskinesia and psychotic symptoms in long-term drug-free inpatients with schizophrenia. 89
Dopamine-glutamate interaction and antipsychotics mechanism of action: implication for new pharmacological strategies in psychosis. 89
Linking Inflammation, Aberrant Glutamate-Dopamine Interaction, and Post-synaptic Changes: Translational Relevance for Schizophrenia and Antipsychotic Treatment: a Systematic Review 88
Canonical and Non-Canonical Antipsychotics' Dopamine-Related Mechanisms of Present and Next Generation Molecules: A Systematic Review on Translational Highlights for Treatment Response and Treatment-Resistant Schizophrenia 88
The Neurobiological Underpinnings of Obsessive-Compulsive Symptoms in Psychosis, Translational Issues for Treatment-Resistant Schizophrenia 88
Method for quantitative in situ hybridization histochemistry and image analysis applied for Homer1a gene expression in rat brain 88
Dopamine transporter (DAT) genetic hypofunction in mice produces alterations consistent with ADHD but not schizophrenia or bipolar disorder 88
Translating preclinical findings in clinically relevant new antipsychotic targets: focus on the glutamatergic postsynaptic density. Implications for treatment resistant schizophrenia 88
Ketamine-related expression of glutamatergic postsynaptic density genes: possible implications in psychosis 87
Neurobiological correlates of anxiety treatment.(Le basi neurobiologiche della terapia dell’ansia) 87
Totale 10.054
Categoria #
all - tutte 64.294
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.294


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021304 0 0 0 0 0 97 43 3 76 21 36 28
2021/2022957 14 1 8 11 8 46 22 32 158 78 160 419
2022/20231.176 191 95 34 49 138 160 14 107 156 101 87 44
2023/20241.009 33 144 91 92 58 51 60 159 35 26 167 93
2024/20256.409 318 422 16 55 169 317 712 441 484 647 2.203 625
2025/20267.516 1.477 1.039 1.436 1.039 2.193 332 0 0 0 0 0 0
Totale 19.148